This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ashland (ASH) Wraps Up Expansion of Viatel Polymers Site
by Zacks Equity Research
Ashland's (ASH) site expansion enables it to focus on catering the needs of consumers as they pursue clinical studies and prepare for commercialization.
Ashland (ASH) to Increase Prices for Adhesives Products
by Zacks Equity Research
Ashland's (ASH) price increase is in response of the continuous cost increase in feedstock, key raw materials and freight.
Ashland (ASH) Down 1.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hawkins (HWKN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Hawkins (HWKN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Ashland (ASH) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Ashland (ASH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ashland's (ASH) Earnings and Sales Surpass Estimates in Q1
by Zacks Equity Research
Ashland (ASH) benefits from strong overall demand and cost-reduction actions in the fiscal first quarter.
Ashland (ASH) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 50.00% and 1.58%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) Up 1.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 Chemical Specialty Stocks to Escape Industry Challenges
by Anindya Barman
Soft demand amid sluggish industrial activities due to coronavirus clouds prospects for the Zacks Chemicals Specialty industry. Quaker Chemical (KWR), Valvoline (VVV), Element Solutions (ESI) and Ingevity (NGVT) are set to gain from self-help actions.
Ashland's (ASH) Earnings and Sales Surpass Estimates in Q4
by Zacks Equity Research
Ashland (ASH) gains from strength in Consumer Specialties and improved demand within Industrial Specialties in Q4.
What Makes Ashland (ASH) a New Buy Stock
by Zacks Equity Research
Ashland (ASH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ashland (ASH) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 25.32% and 4.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
W.R. Grace (GRA) Catches Eye: Stock Jumps 9.2%
by Zacks Equity Research
W.R. Grace (GRA) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
5 Top US Specialty Chemical Stocks to Snap Up on Demand Upturn
by Anindya Barman
A revival in demand across major end-markets such as automotive and construction represents a tailwind for the U.S. specialty chemical industry. ASH, AXTA, VVV, KWR and ESI are well placed to make the most of the improving demand.
What Makes Ashland (ASH) a New Strong Buy Stock
by Zacks Equity Research
Ashland (ASH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
5 Chemical Growth Stocks to Enrich Your Portfolio in Q4
by Anindya Barman
The chemical industry is looking up after bearing the brunt of coronavirus fallout, aided by a return of global economic activities.
Ingevity Gains on Cost Actions Amid Weak Industrial Demand
by Anindya Barman
Ingevity (NGVT) benefits from cost-reduction measures and growth in its applications driven by regulations and technology adoption.
Global Chemical Output Growth Speeds Up as Activities Recover
by Anindya Barman
Global chemical production growth accelerates in August on gains across all regions and industry segments.
All You Need to Know About Ashland (ASH) Rating Upgrade to Strong Buy
by Zacks Equity Research
Ashland (ASH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
5 Chemical Stocks to Snap Up on Global Manufacturing Revival
by Anindya Barman
With China seeing an economic rebound and manufacturing activities are improving around the world, things are looking up for the chemical industry.
Global Chemical Output Up As Activity Picks Up in Key Regions
by Anindya Barman
Global chemical production rose 1.4% in July on gains across all chemical industry segments.
Ashland (ASH) Down 2.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
US Specialty Chemical Volumes Expand in July: 4 Top Picks
by Anindya Barman
The rebound in manufacturing activity and continued recovery in the U.S. economy are likely to act as a tailwind for the U.S. specialty chemical industry.
Moving Average Crossover Alert: Ashland Global
by Zacks Equity Research
Ashland Global is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.